17β-Hydroxysteroid dehydrogenases (17β-HSDs) regulate androgen and estrogen concentrations in mammals. By 1995, four distinct enzymes with 17β-HSD activity had been identified — 17β-HSD-types 1 and 3, which, in vivo, are NADPH-dependent reductases; and 17β-HSD-types 2 and 4, which, in vivo, are NAD +-dependent oxidases. Since then, six additional enzymes with 17β-HSD activity have been isolated from mammals. With the exception of 17β-HSD-type 5, which belongs to the aldoketo-reductase (AKR) family, these 17β-HSDs belong to the short chain dehydrogenase/reductase (SDR) family. Several 17β-HSDs appear to be examples of convergent evolution. That is, 17β-HSD activity arose several times from different ancestors. Some 17β-HSDs share a common ancestor with retinoid oxido-reductases and have retinol dehydrogenase activity. 17β-HSD-types 2, 6 and 9 appear to have diverged from ancestral retinoid dehydrogenases early in the evolution of deuterostomes during the Cambrian, about 540 million years ago. This coincided with the origin of nuclear receptors for androgens and estrogens suggesting that expression of 17β-HSDs had an important role in the early evolution of the physiological response to androgens and estrogens.